<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet href="/tresources/styles/tendenci-rss.xsl" type="text/xsl" media="screen"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>MyBeautifulLegs.com - Articles</title>
<itunes:subtitle>MyBeautifulLegs.com Article RSS</itunes:subtitle>
<link>http://www.mybeautifullegs.com</link>
<description>MyBeautifulLegs.com Article RSS feed. .</description>
<itunes:author>MyBeautifulLegs.com</itunes:author>
<image>
<url>http://www.mybeautifullegs.com/tresources/en/images/icons/tendenci34x15.gif</url>
<title>MyBeautifulLegs.com</title><link>http://www.mybeautifullegs.com</link>
</image>
<itunes:image href="http://www.mybeautifullegs.com/tresources/en/images/icons/tendenci34x15.gif" />
<itunes:explicit>no</itunes:explicit>
<copyright>Copyright 2005, MyBeautifulLegs.com</copyright>
<generator>Tendenci Membership Management Software by Schipul - The Web Marketing Company</generator>
<language>en-us</language>
<webMaster>noemail@mybeautifullegs.com</webMaster>
<pubDate>Fri, 10 Sep 2010 03:32:16 GMT</pubDate>
		<item>

			<category>Articles</category>
			<link>http://www.mybeautifullegs.com/en/art/522/</link>
			<title>COSMETIC 14093:  Recommendations for Patient Safety in Body Contouring Surgery After a Review of 4,000 Consecutive Cases</title>
			<description>COSMETIC 14093:&amp;nbsp; Recommendations for Patient Safety in Body Contouring Surgery After a Review of 4,000 Consecutive Cases&lt;br&gt;
Christopher K. Patronella, MD, FACS&lt;br&gt;
Amado Ruiz-Razura, MD, FACS; German Newall, MD, FACS; Henry A. Mentz, MD, FACS &lt;br&gt;
ACCEPTED&lt;br&gt;
Topic Selection: Cosmetic IV (1628)&lt;br&gt;
Preferred Presentation Format: Paper&lt;br&gt;
Abstract&lt;br&gt;
In recent years, there has been an increasing demand among plastic surgeons for patient safety that specifically addresses the complications suffered by certain patients regarding deep venous thrombosis (DVT) and pulmonary embolism (PE). In a survey conducted by Broughton et al. [4], he reveals that less than 50% of plastic surgeons use thromboprophylaxis as part of their standard protocol when performing aesthetic surgery.&amp;nbsp; Pulmonary embolism represents the third highest cause of postoperative death in the US. Unfortunately, current data regarding this problem connected to aesthetic surgery is very limited. For this reason, it is our mission to share with fellow plastic surgeons our experiences taken from 17 patients, who have suffered from DVT/PE complications, in a review of 3,871 consecutive procedures performed over the last seven years in our center. &lt;br&gt;
We conducted a retrospective chart review to identity the common factors responsible for causing DVT/PE among those high-risk patients who undergo aesthetic surgery.&amp;nbsp; Of these cases, we have calculated the following incidence rates: 0.46% for DVT, and 0.08% for PE.&amp;nbsp; We discovered that a culmination of factors working in a synergistic way plays a significant role in the development of DVT/PE. We conclude that a carefully planned out, comprehensive, appropriately enforced protocol is necessary to reduce the rate of thromboembolic events.&amp;nbsp; Practical safety measures and technical recommendations are presented that strongly encourages the use of thromboprophylaxis during the preoperative, intraoperative and postoperative phases of aesthetic surgical procedures.&amp;nbsp; Feel that DVT and PE should be an equal partnership between patient and surgeon. &lt;br&gt;
&amp;nbsp; &lt;br&gt;
Type of Clinical Question: Therapeutic&lt;br&gt;
Clinical Question: It is the purpose of this study to review 3,871 consecutive high-risk cases and identity common factors that could have contributed to the onset of DVT/PE in 17 patients. The close evaluation of these 17 cases was conducted with an effort to determine if there were contributing factors that we could have been prevented and if not, how to implement a sound and prompt management to these serious problems and finding practical, prompt and efficient ways to prevent them in the future. We present our safety guidelines that resulted from the review of these 17 patients that encountered DVT and PE to be used for the implementation of thromboprophylaxis in the high risk and highest risk patient. We also provide our recommendations for the preoperative, intraoperative, and postoperative phases of surgery based in our experience with these 3,871 cases. &lt;br&gt;
Inclusion/Exclusion Criteria for Study Population: All patients were part of the private group practice, all female, with a preoperative classification as high risk and highest risk cases. They all had an abdominoplasty, high volume liposuction an other added combination procedures performed during one operative session. All had to be discharged at 23 hours post surgery&lt;br&gt;
Intervention/Exposure of Interest: Among those patients who presented complications, we carefully evaluated the following parameters: age, weight, body mass index (BMI), past medical history including medications, surgical, family and social history. In addition, during the course of surgery, we evaluated the duration of the procedure, amount of tumescent infiltration, the patient's total aspiration volume, the amount of tissue removed during surgery, and the patient's temperature throughout the pre, intra, and postoperative periods. A postoperative evaluation was also performed, taking into account any complications, such as the date and time when signs and symptoms were first noticed, and analysis of the different methods used to verify such complications such as the use of venous Doppler scan, Spiral CT Scan, and V/Q Scan. &lt;br&gt;
Outcomes of Interest: After collecting preliminary information from the 3,871 patients, a group of statistics provided several analyses and projections. First, patients were sort in two groups and a sample size was determined for each group. Group Number I involved patients that suffered DVT/PE (sample size = 17), and Group Number II patients that did not presented signs and symptoms of DVT/PE complications (sample size = 3,854 patients). Then, the two-sample t-test was applied to compare both groups and a logistic regression model was created to predict the probability of having DVT complications in patients who undergo aesthetic surgery performed by the Department of Industrial Engineering- Section of Statistics at the University of Houston.&lt;br&gt;
Type of Study: Case Series&lt;br&gt;
Time Period: Retrospective&lt;br&gt;
Controls: N/A&lt;br&gt;
Randomization Method: Computer generated&lt;br&gt;
Allocation Concealment/Blinding: N/A&lt;br&gt;
Study Procedures: The study procedures conducted reflected a median age: 39 years, median height: 5&#8217;4&#8221;, median weight: 185 lbs, median BMI: 29.9. From the 17 patients with serious complications, 31% were categorized as ASA I, 56% as ASA II, and only 13% oas ASA III. When we combined this data with the Georgetown Risk Assessment Classification model, ALL patients were at the high-risk or highest risk level. Within this Classification , seven patients of the 17 fell into the high-risk category while the other 10 patients fell into the highest risk category. Those that were among the highest risk patients all exhibited more than four of the discovered factors to predispose them to develop DVT and PE. The average surgical duration: 5h 25 min ; average aspiration volume: 6,437 cc; average body temperature: 35.1&amp;#176; C . From the 17 patients, 12 developed deep venous thrombosis, and 3 developed pulmonary embolism, while two patients developed both events. An incidence rate of 0.42% was derived, and no mortality was encountered in this study. Signs and symptoms for DVT/PE complications, initiated from 3 to 23 days post surgery with an average of 11 days. Upon close review, 70% of these patients were diagnosed as having a predisposition for thrombogenesis caused by increased levels of clotting factors or inherited or acquired thrombophilias. At least 58% of the patients, were taking oral contraceptives or undergoing hormone replacement therapy. 80% of the patients using hormone replacement therapy were also &amp;#8805; 20% over their ideal body weight. One of our patients tested positive for Lupus another was positive for Factor V Von Leiden mutation. One patient who was taking hormone replacement therapy, tested positive for a prothrombin mutation and exhibited low levels of protein C and S. Another patient had elevated levels of homocysteine. &lt;br&gt;
Statistical Methods: Table IV. Explanation of statistical analysis model used in this study. A logistic regression model in order to predict the probability of having DVT complication based on the values of these characteristics of the patient, the model can be presented as following: Where: Pr(DVT) = probability of the patient having the DVT complication. BMI = the value of Body Mass Index of the patient Temp = the value of the room temperature of the patient in Fahrenheit TT = 1 if the &#8220;Tummy Tuck&#8221; procedure is performed on the patient, 0 otherwise BodyL = 1 if the &#8220;Body Lifting&#8221; procedure is performed on the patient, 0 otherwise We used this model to predict the probability of having the DVT complication on 117 patients. The model correctly predicts the result about 90% of the times. &lt;br&gt;
Representation of Data: After performing a number of statistical analyses on two groups of patients Group 1: patients with DVT complication (sample size = 17) and Group 2: patients without DVT complication (sample size = 100), our data indicates: Comparative Analysis Between the Thrombogenic and the Non-Thrombogenic Groups. Category Unit I - Thrombogenic Group N= 17 II - Non- Thrombogenic Group N= 100 p-value for Comparing Mean Mean Standard Deviation Mean Standard Deviation Age (year) 39.94 9.74 39.2 11.1 0.389 Pre-Weight (lbs) 178.5 33.1 165.4 34.6 0.076 Height (cm) 162.11 6.49 165.63 7.95 0.03 BMI (index) 30.95 6.41 27.23 4.59 0.017 Length of Surgery (minutes) 282 135 201 131 0.023 Patient Temperature (0F) 95.23 1.97 95.93 1.57 0.105 Total Fat Removed (cc) 6509 4883 4715 2889 0.08 Intra Venous Fluids (ml) 2533 1767 2174 998 0.228 Proportion of Patient Performed Tummy Tuck 0.706 0.47 0.379 0.488 0.008 Proportion of Patient Performed Body Lifting 0.294 0.47 0.046 0.211 0.024 &lt;br&gt;
Answer to Clinical Question: It is not our recommendation that every patient undergoes arduous and costly examinations to determine all genetic disorders and problems, which may arise before performing aesthetic surgery since this is not a realistic approach in terms of cost efficiency. However, the best approach, in our opinion, is for the surgeon to incorporate their own guidelines including the preventive measures discussed above to prevent the increased risk of DVT and PE. Once a preventive plan has been established, the surgeon must educate the patient about the possible signs and symptoms that may occur, and stress the importance of the patient communicating any concerns or symptoms immediately so that the physician can promptly diagnose and treat effectively. We cannot emphasize enough the need to have a thorough understanding and a comprehensive and proactive approach to DVT and PE, not only by the surgeon and anesthesiologist but throughout the entire surgical and nursing staff. Being compulsive and reacting promptly and effectively to early signs of thromboembolism has saved us from many problems and any fatalities. We conclude that all 17 patients that developed DVT and PE complications from the 3,871 consecutive cases reviewed, all were able to recover fully from their complication with no long-term effects from the thromboembolic event, and they are satisfied with the results of their surgery. We appreciate their cooperation in allowing us to collect the much-needed data that enabled us to report our experience intended to promote patient&#8217;s safety and the advancement of thromboembolism prophylaxis in aesthetic plastic surgery. &lt;br&gt;
Discussion: We emphasize the effective use of sequential compression devices and anticoagulants to serve as a preventive measure among DVT/PE candidates who present elevated risk factors. It is not cost-effective to conduct extensive tests on all patients for each type of coagulopathy disorder. The plastic surgeon should implement a standard antithrombolytic regimen for those patients who exhibit the aforementioned factors placing them into a high risk category in order to decrease the incidence of DVT/PE. Sequential compression devices should be used as the standard of care in all patients under general anesthesia for 2 hours or more. Further considerations include the temporary discontinuation of hormonal therapy at least 4 weeks prior to surgery to ensure return of fibrinogen to normal level . We advise patients to consume multivitamins that contain folic acid &amp;amp; B complex to avoid elevated homocysteine levels at least two weeks prior to surgery. Reducing the patient's risk of hypothermia may reduce the risk of DVT by avoiding vasoconstriction and venous stasis . We feel that perioperative hypothermia can be accomplished by: 1: Use of &quot;Bear Hugger&quot; gowns; 2: Warming IV fluids and tumescent solutions; 3: Using warm humidified oxygen applied as a circuit warmer 4: Minimizing the surface area of exposure during surgery using sterile warmed blankets. The use of regional infusion pain pumps , to help with early ambulation along with the administration of low-molecular-weight-heparin such as Enoxaparin (Lovenox) 40 mg/day beginning on post operative day 1 and continuing for 2 more days. In this study, an early diagnosis and immediate aggressive treatment was instituted, preventing a potential catastrophic death. There needs to exist an open line of communication between the patient and their family and the surgeon and his staff in order to help promote the prevention and early detection of DVT and PE. &lt;br&gt;
&amp;nbsp; 
&lt;br&gt;&lt;br&gt;21-Nov-08 10:00 AM
</description>
			<itunes:subtitle>COSMETIC 14093:  Recommendations for Patient Safety in Body Contouring Surgery After a Review of 4,000 Consecutive Cases</itunes:subtitle>
			<itunes:summary>COSMETIC 14093:&amp;nbsp; Recommendations for Patient Safety in Body Contouring Surgery After a Review of 4,000 Consecutive Cases&lt;br&gt;
Christopher K. Patronella, MD, FACS&lt;br&gt;
Amado Ruiz-Razura, MD, FACS; German Newall, MD, FACS; Henry A. Mentz, MD, FACS &lt;br&gt;
ACCEPTED&lt;br&gt;
Topic Selection: Cosmetic IV (1628)&lt;br&gt;
Preferred Presentation Format: Paper&lt;br&gt;
Abstract&lt;br&gt;
In recent years, there has been an increasing demand among plastic surgeons for patient safety that specifically addresses the complications suffered by certain patients regarding deep venous thrombosis (DVT) and pulmonary embolism (PE). In a survey conducted by Broughton et al. [4], he reveals that less than 50% of plastic surgeons use thromboprophylaxis as part of their standard protocol when performing aesthetic surgery.&amp;nbsp; Pulmonary embolism represents the third highest cause of postoperative death in the US. Unfortunately, current data regarding this problem connected to aesthetic surgery is very limited. For this reason, it is our mission to share with fellow plastic surgeons our experiences taken from 17 patients, who have suffered from DVT/PE complications, in a review of 3,871 consecutive procedures performed over the last seven years in our center. &lt;br&gt;
We conducted a retrospective chart review to identity the common factors responsible for causing DVT/PE among those high-risk patients who undergo aesthetic surgery.&amp;nbsp; Of these cases, we have calculated the following incidence rates: 0.46% for DVT, and 0.08% for PE.&amp;nbsp; We discovered that a culmination of factors working in a synergistic way plays a significant role in the development of DVT/PE. We conclude that a carefully planned out, comprehensive, appropriately enforced protocol is necessary to reduce the rate of thromboembolic events.&amp;nbsp; Practical safety measures and technical recommendations are presented that strongly encourages the use of thromboprophylaxis during the preoperative, intraoperative and postoperative phases of aesthetic surgical procedures.&amp;nbsp; Feel that DVT and PE should be an equal partnership between patient and surgeon. &lt;br&gt;
&amp;nbsp; &lt;br&gt;
Type of Clinical Question: Therapeutic&lt;br&gt;
Clinical Question: It is the purpose of this study to review 3,871 consecutive high-risk cases and identity common factors that could have contributed to the onset of DVT/PE in 17 patients. The close evaluation of these 17 cases was conducted with an effort to determine if there were contributing factors that we could have been prevented and if not, how to implement a sound and prompt management to these serious problems and finding practical, prompt and efficient ways to prevent them in the future. We present our safety guidelines that resulted from the review of these 17 patients that encountered DVT and PE to be used for the implementation of thromboprophylaxis in the high risk and highest risk patient. We also provide our recommendations for the preoperative, intraoperative, and postoperative phases of surgery based in our experience with these 3,871 cases. &lt;br&gt;
Inclusion/Exclusion Criteria for Study Population: All patients were part of the private group practice, all female, with a preoperative classification as high risk and highest risk cases. They all had an abdominoplasty, high volume liposuction an other added combination procedures performed during one operative session. All had to be discharged at 23 hours post surgery&lt;br&gt;
Intervention/Exposure of Interest: Among those patients who presented complications, we carefully evaluated the following parameters: age, weight, body mass index (BMI), past medical history including medications, surgical, family and social history. In addition, during the course of surgery, we evaluated the duration of the procedure, amount of tumescent infiltration, the patient's total aspiration volume, the amount of tissue removed during surgery, and the patient's temperature throughout the pre, intra, and postoperative periods. A postoperative evaluation was also performed, taking into account any complications, such as the date and time when signs and symptoms were first noticed, and analysis of the different methods used to verify such complications such as the use of venous Doppler scan, Spiral CT Scan, and V/Q Scan. &lt;br&gt;
Outcomes of Interest: After collecting preliminary information from the 3,871 patients, a group of statistics provided several analyses and projections. First, patients were sort in two groups and a sample size was determined for each group. Group Number I involved patients that suffered DVT/PE (sample size = 17), and Group Number II patients that did not presented signs and symptoms of DVT/PE complications (sample size = 3,854 patients). Then, the two-sample t-test was applied to compare both groups and a logistic regression model was created to predict the probability of having DVT complications in patients who undergo aesthetic surgery performed by the Department of Industrial Engineering- Section of Statistics at the University of Houston.&lt;br&gt;
Type of Study: Case Series&lt;br&gt;
Time Period: Retrospective&lt;br&gt;
Controls: N/A&lt;br&gt;
Randomization Method: Computer generated&lt;br&gt;
Allocation Concealment/Blinding: N/A&lt;br&gt;
Study Procedures: The study procedures conducted reflected a median age: 39 years, median height: 5&#8217;4&#8221;, median weight: 185 lbs, median BMI: 29.9. From the 17 patients with serious complications, 31% were categorized as ASA I, 56% as ASA II, and only 13% oas ASA III. When we combined this data with the Georgetown Risk Assessment Classification model, ALL patients were at the high-risk or highest risk level. Within this Classification , seven patients of the 17 fell into the high-risk category while the other 10 patients fell into the highest risk category. Those that were among the highest risk patients all exhibited more than four of the discovered factors to predispose them to develop DVT and PE. The average surgical duration: 5h 25 min ; average aspiration volume: 6,437 cc; average body temperature: 35.1&amp;#176; C . From the 17 patients, 12 developed deep venous thrombosis, and 3 developed pulmonary embolism, while two patients developed both events. An incidence rate of 0.42% was derived, and no mortality was encountered in this study. Signs and symptoms for DVT/PE complications, initiated from 3 to 23 days post surgery with an average of 11 days. Upon close review, 70% of these patients were diagnosed as having a predisposition for thrombogenesis caused by increased levels of clotting factors or inherited or acquired thrombophilias. At least 58% of the patients, were taking oral contraceptives or undergoing hormone replacement therapy. 80% of the patients using hormone replacement therapy were also &amp;#8805; 20% over their ideal body weight. One of our patients tested positive for Lupus another was positive for Factor V Von Leiden mutation. One patient who was taking hormone replacement therapy, tested positive for a prothrombin mutation and exhibited low levels of protein C and S. Another patient had elevated levels of homocysteine. &lt;br&gt;
Statistical Methods: Table IV. Explanation of statistical analysis model used in this study. A logistic regression model in order to predict the probability of having DVT complication based on the values of these characteristics of the patient, the model can be presented as following: Where: Pr(DVT) = probability of the patient having the DVT complication. BMI = the value of Body Mass Index of the patient Temp = the value of the room temperature of the patient in Fahrenheit TT = 1 if the &#8220;Tummy Tuck&#8221; procedure is performed on the patient, 0 otherwise BodyL = 1 if the &#8220;Body Lifting&#8221; procedure is performed on the patient, 0 otherwise We used this model to predict the probability of having the DVT complication on 117 patients. The model correctly predicts the result about 90% of the times. &lt;br&gt;
Representation of Data: After performing a number of statistical analyses on two groups of patients Group 1: patients with DVT complication (sample size = 17) and Group 2: patients without DVT complication (sample size = 100), our data indicates: Comparative Analysis Between the Thrombogenic and the Non-Thrombogenic Groups. Category Unit I - Thrombogenic Group N= 17 II - Non- Thrombogenic Group N= 100 p-value for Comparing Mean Mean Standard Deviation Mean Standard Deviation Age (year) 39.94 9.74 39.2 11.1 0.389 Pre-Weight (lbs) 178.5 33.1 165.4 34.6 0.076 Height (cm) 162.11 6.49 165.63 7.95 0.03 BMI (index) 30.95 6.41 27.23 4.59 0.017 Length of Surgery (minutes) 282 135 201 131 0.023 Patient Temperature (0F) 95.23 1.97 95.93 1.57 0.105 Total Fat Removed (cc) 6509 4883 4715 2889 0.08 Intra Venous Fluids (ml) 2533 1767 2174 998 0.228 Proportion of Patient Performed Tummy Tuck 0.706 0.47 0.379 0.488 0.008 Proportion of Patient Performed Body Lifting 0.294 0.47 0.046 0.211 0.024 &lt;br&gt;
Answer to Clinical Question: It is not our recommendation that every patient undergoes arduous and costly examinations to determine all genetic disorders and problems, which may arise before performing aesthetic surgery since this is not a realistic approach in terms of cost efficiency. However, the best approach, in our opinion, is for the surgeon to incorporate their own guidelines including the preventive measures discussed above to prevent the increased risk of DVT and PE. Once a preventive plan has been established, the surgeon must educate the patient about the possible signs and symptoms that may occur, and stress the importance of the patient communicating any concerns or symptoms immediately so that the physician can promptly diagnose and treat effectively. We cannot emphasize enough the need to have a thorough understanding and a comprehensive and proactive approach to DVT and PE, not only by the surgeon and anesthesiologist but throughout the entire surgical and nursing staff. Being compulsive and reacting promptly and effectively to early signs of thromboembolism has saved us from many problems and any fatalities. We conclude that all 17 patients that developed DVT and PE complications from the 3,871 consecutive cases reviewed, all were able to recover fully from their complication with no long-term effects from the thromboembolic event, and they are satisfied with the results of their surgery. We appreciate their cooperation in allowing us to collect the much-needed data that enabled us to report our experience intended to promote patient&#8217;s safety and the advancement of thromboembolism prophylaxis in aesthetic plastic surgery. &lt;br&gt;
Discussion: We emphasize the effective use of sequential compression devices and anticoagulants to serve as a preventive measure among DVT/PE candidates who present elevated risk factors. It is not cost-effective to conduct extensive tests on all patients for each type of coagulopathy disorder. The plastic surgeon should implement a standard antithrombolytic regimen for those patients who exhibit the aforementioned factors placing them into a high risk category in order to decrease the incidence of DVT/PE. Sequential compression devices should be used as the standard of care in all patients under general anesthesia for 2 hours or more. Further considerations include the temporary discontinuation of hormonal therapy at least 4 weeks prior to surgery to ensure return of fibrinogen to normal level . We advise patients to consume multivitamins that contain folic acid &amp;amp; B complex to avoid elevated homocysteine levels at least two weeks prior to surgery. Reducing the patient's risk of hypothermia may reduce the risk of DVT by avoiding vasoconstriction and venous stasis . We feel that perioperative hypothermia can be accomplished by: 1: Use of &quot;Bear Hugger&quot; gowns; 2: Warming IV fluids and tumescent solutions; 3: Using warm humidified oxygen applied as a circuit warmer 4: Minimizing the surface area of exposure during surgery using sterile warmed blankets. The use of regional infusion pain pumps , to help with early ambulation along with the administration of low-molecular-weight-heparin such as Enoxaparin (Lovenox) 40 mg/day beginning on post operative day 1 and continuing for 2 more days. In this study, an early diagnosis and immediate aggressive treatment was instituted, preventing a potential catastrophic death. There needs to exist an open line of communication between the patient and their family and the surgeon and his staff in order to help promote the prevention and early detection of DVT and PE. &lt;br&gt;
&amp;nbsp;</itunes:summary>
<itunes:explicit>no</itunes:explicit>
			<guid isPermaLink="false">http://www.mybeautifullegs.com/en/art/522/</guid>
			<author>Louis Provenzano</author>
			<pubDate>Fri, 21 Nov 2008 16:00:00 GMT</pubDate>
		</item>

</channel></rss>